Skip to content

Author

Hanzong Zhou

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Meta-analysis Open access Aug 2026

Meta-analysis and pharmacoeconomic study of rasagiline versus selegiline in the treatment of Parkinson’s disease

Abstract Objective Given the persistent absence of direct head-to-head trials, this study aimed to evaluate the comparative efficacy, safety, and cost-effectiveness of rasagiline versus selegiline as early-stage monotherapy for Parkinson’s disease (PD), informing clinical selection and healthcare policies in China. Met...

Hanzong Zhou, Dandan Li, Jun-Xian Yu et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.